Children's Hospital of Philadelphia Secures $1.8M in Cancer Research Grants
Event summary
- Children's Hospital of Philadelphia (CHOP) received $1.8 million in grants from the V Foundation for Cancer Research.
- Andrei Thomas-Tikhonenko, PhD, received a $1 million grant to develop a novel CAR T-cell therapy for T-cell acute lymphoblastic leukemia (T-ALL).
- Suzanne MacFarland, MD, received an $800,000 grant to study a blood-based 'liquid biopsy' approach for early cancer detection in Li-Fraumeni syndrome patients.
- The grants aim to address disparities in cancer outcomes and advance clinical trials for pediatric cancer care.
The big picture
The grants highlight CHOP's focus on innovative pediatric cancer research, particularly in targeted immunotherapies and early detection methods. The V Foundation's significant investment underscores the strategic importance of addressing both treatment-resistant leukemias and genetic predispositions to cancer. This funding could accelerate breakthroughs in pediatric oncology, potentially improving outcomes for high-risk patient populations.
What we're watching
- Clinical Trial Progress
- The pace at which the P2RX5-targeted CAR T-cell therapy advances to a first-in-human clinical trial.
- Early Detection Feasibility
- Whether the liquid biopsy approach for Li-Fraumeni syndrome patients proves feasible for broader application.
- Disparity Reduction
- How effectively the research addresses disparities in cancer outcomes among children of African and Hispanic ancestry.
Related topics